BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3054659)

  • 21. [Pregnancies in spite of intrauterine pessaries in situ].
    Zielske F; Becker K; Knauf P
    Geburtshilfe Frauenheilkd; 1977 Jun; 37(6):473-84. PubMed ID: 885320
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ovarian pregnancy: association with IUD, pelvic pathology and recurrent abortion.
    Reichman J; Goldman JA; Feldberg D
    Eur J Obstet Gynecol Reprod Biol; 1981 Dec; 12(6):333-7. PubMed ID: 7333410
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The use of three-dimensional ultrasound imaging in detecting the type and location of intrauterine contraceptive device].
    Zhang S; Ying W; Xu J; Yang M; Xu K; Luo Q
    Zhonghua Yi Xue Za Zhi; 2002 Apr; 82(7):459-61. PubMed ID: 12133515
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hysteroscopic removal of intrauterine devices in pregnancy.
    Sanders AP; Sanders B
    Fertil Steril; 2018 Dec; 110(7):1408-1409. PubMed ID: 30503139
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Migration of intrauterine devices: radiologic findings and implications for patient care.
    Boortz HE; Margolis DJ; Ragavendra N; Patel MK; Kadell BM
    Radiographics; 2012; 32(2):335-52. PubMed ID: 22411936
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Menstrual characteristics and ultrasonographic uterine cavity measurements predict bleeding and pain in nulligravid women using intrauterine contraception.
    Kaislasuo J; Heikinheimo O; Lähteenmäki P; Suhonen S
    Hum Reprod; 2015 Jul; 30(7):1580-8. PubMed ID: 25990577
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Surface changes in intrauterine contraceptive devices after variable use.
    Keith L; Bailey R; Berger GS; Method M
    Am J Obstet Gynecol; 1985 May; 152(1):69-78. PubMed ID: 3993713
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Intrauterine contraceptive devices. Mode of action, experiences, complications (author's transl)].
    Ludwig H
    Geburtshilfe Frauenheilkd; 1976 Feb; 36(2):97-108. PubMed ID: 943359
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ultrasound Assessment of the Intrauterine Device.
    Evans AT; Szlachetka K; Thornburg LL
    Obstet Gynecol Clin North Am; 2019 Dec; 46(4):661-681. PubMed ID: 31677748
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Posplacenta intrauterine device. Guide wires not visible].
    Lara Ricalde R; Velázquez Ramírez N; Reyes Muñoz E; Baca Olivo Pdel R
    Ginecol Obstet Mex; 2012 Mar; 80(3):201-7. PubMed ID: 22812176
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intrauterine device failure: relation to its location within the uterine cavity.
    Anteby E; Revel A; Ben-Chetrit A; Rosen B; Tadmor O; Yagel S
    Obstet Gynecol; 1993 Jan; 81(1):112-4. PubMed ID: 8416443
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Two cases of uterine septum with intrauterine device.
    Dikensoy E; Kutlar I; Gocmen A; Graves CR
    Br J Radiol; 2005 Oct; 78(934):952-3. PubMed ID: 16177021
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Ultra sonography for the localization of intra-uterine contraceptive devices (i.u.d.'s) (author's transl)].
    Meyenburg M
    Geburtshilfe Frauenheilkd; 1978 Nov; 38(11):950-7. PubMed ID: 710881
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Management of the lost intrauterine contraceptive device.
    Shapiro AG
    Obstet Gynecol; 1977 Feb; 49(2):238-40. PubMed ID: 834409
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New observations in the sonographic evaluation of intrauterine contraceptive devices.
    Najarian KE; Kurtz AB
    J Ultrasound Med; 1986 Apr; 5(4):205-10. PubMed ID: 3514951
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Laparoscopic removal of translocated intrauterine contraceptives devices.
    McKenna PJ; Mylotte MJ
    Br J Obstet Gynaecol; 1982 Feb; 89(2):163-5. PubMed ID: 6461352
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative contraceptive effectiveness of levonorgestrel-releasing and copper intrauterine devices: the European Active Surveillance Study for Intrauterine Devices.
    Heinemann K; Reed S; Moehner S; Minh TD
    Contraception; 2015 Apr; 91(4):280-3. PubMed ID: 25601350
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chlamydial serologic characteristics among intrauterine contraceptive device users: does copper inhibit chlamydial infection in the female genital tract?
    Mehanna MT; Rizk MA; Ramadan M; Schachter J
    Am J Obstet Gynecol; 1994 Sep; 171(3):691-3. PubMed ID: 8092216
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Intrauterine contraception. Risks, indications, trends].
    Tauber PF
    Fortschr Med; 1982 May; 100(19):904-12. PubMed ID: 7095705
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Value of hysteroscopy in the removal of intrauterine devices lacking an examination string].
    Khrouf M; Slim N; Zouari F; Chelli H; Chelli M
    Tunis Med; 1985; 63(8-9):475-7. PubMed ID: 4089991
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.